Literature DB >> 1646485

Cholangiocarcinoma complicating primary sclerosing cholangitis.

C B Rosen1, D M Nagorney.   

Abstract

Clinical experience and pathologic evidence strongly support an association between PSC and cholangiocarcinoma. Cholangiocarcinoma arises in 5 to 10% of patients with preexisting PSC and can also present in a synchronous fashion with PSC. Cholangiocarcinoma complicating PSC is heralded by rapid clinical deterioration with progressive jaundice, weight loss, and abdominal discomfort. These tumors have been most frequently detected at an advanced stage, which precludes potentially curative resection. Liver transplantation for locally advanced and incidentally discovered tumors has been fraught with frequent tumor recurrence. Regardless of therapy, the prognosis for patients with cholangiocarcinoma complicating PSC has been uniformly poor. There is a clear need for heightened clinical awareness, methods for earlier detection, and effective therapy for patients with cholangiocarcinoma complicating PSC.

Entities:  

Mesh:

Year:  1991        PMID: 1646485     DOI: 10.1055/s-2008-1040419

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  19 in total

Review 1.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Role of endoscopy in primary sclerosing cholangitis.

Authors:  Nabeel S Koro; Samer Alkaade
Journal:  Curr Gastroenterol Rep       Date:  2013-12

Review 3.  Liver transplantation for cholangiocarcinoma: Current status and new insights.

Authors:  Gonzalo Sapisochín; Elena Fernández de Sevilla; Juan Echeverri; Ramón Charco
Journal:  World J Hepatol       Date:  2015-10-08

4.  Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation.

Authors:  K M Abu-Elmagd; R Selby; S Iwatsuki; J Fung; A Tzakis; S Todo; A J Demetris; N Baddour; W Irish; D H Van Thiel
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

Review 5.  Primary sclerosing cholangitis.

Authors:  Y Ueno; N F LaRusso
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

Review 6.  Preemptive surgery for premalignant foregut lesions.

Authors:  Rohit R Sharma; Mark J London; Laura L Magenta; Mitchell C Posner; Kevin K Roggin
Journal:  J Gastrointest Surg       Date:  2009-06-10       Impact factor: 3.452

7.  ERCP with probe-based confocal laser endomicroscopy for the evaluation of dominant biliary stenoses in primary sclerosing cholangitis patients.

Authors:  Muhannad Heif; Roy D Yen; Raj J Shah
Journal:  Dig Dis Sci       Date:  2013-03-09       Impact factor: 3.199

8.  Primary Sclerosing Cholangitis: Current and Future Management Strategies.

Authors:  John E Eaton; Jayant A Talwalkar
Journal:  Curr Hepat Rep       Date:  2013-03-01

9.  Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience.

Authors:  Sophie Duignan; Donal Maguire; Chamarajanagar S Ravichand; Justin Geoghegan; Emir Hoti; David Fennelly; John Armstrong; Kathy Rock; Helen Mohan; Oscar Traynor
Journal:  HPB (Oxford)       Date:  2013-04-18       Impact factor: 3.647

10.  Flowcharts for the management of biliary tract and ampullary carcinomas.

Authors:  Shuichi Miyakawa; Shin Ishihara; Tadahiro Takada; Masaru Miyazaki; Kazuhiro Tsukada; Masato Nagino; Satoshi Kondo; Junji Furuse; Hiroya Saito; Toshio Tsuyuguchi; Fumio Kimura; Hideyuki Yoshitomi; Satoshi Nozawa; Masahiro Yoshida; Keita Wada; Hodaka Amano; Fumihiko Miura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.